Long Non-Coding RNA and Acute Leukemia
AbstractAcute leukemia (AL) is the main type of cancer in children worldwide. Mortality by this disease is high in developing countries and its etiology remains unanswered. Evidences showing the role of the long non-coding RNAs (lncRNAs) in the pathophysiology of hematological malignancies have increased drastically in the last decade. In addition to the contribution of these lncRNAs in leukemogenesis, recent studies have suggested that lncRNAs could be used as biomarkers in the diagnosis, prognosis, and therapeutic response in leukemia patients. The focus of this review is to describe the functional classification, biogenesis, and the role of lncRNAs in leukemogenesis, to summarize the evidence about the lncRNAs which are playing a role in AL, and how these genes could be useful as potential therapeutic targets. View Full-Text
Share & Cite This Article
Cruz-Miranda, G.M.; Hidalgo-Miranda, A.; Bárcenas-López, D.A.; Núñez-Enríquez, J.C.; Ramírez-Bello, J.; Mejía-Aranguré, J.M.; Jiménez-Morales, S. Long Non-Coding RNA and Acute Leukemia. Int. J. Mol. Sci. 2019, 20, 735.
Cruz-Miranda GM, Hidalgo-Miranda A, Bárcenas-López DA, Núñez-Enríquez JC, Ramírez-Bello J, Mejía-Aranguré JM, Jiménez-Morales S. Long Non-Coding RNA and Acute Leukemia. International Journal of Molecular Sciences. 2019; 20(3):735.Chicago/Turabian Style
Cruz-Miranda, Gabriela M.; Hidalgo-Miranda, Alfredo; Bárcenas-López, Diego A.; Núñez-Enríquez, Juan C.; Ramírez-Bello, Julian; Mejía-Aranguré, Juan M.; Jiménez-Morales, Silvia. 2019. "Long Non-Coding RNA and Acute Leukemia." Int. J. Mol. Sci. 20, no. 3: 735.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.